Veraxa Biotech is trading at $2.37 (7.7%) up today, marking a technical bounce after several consecutive days of losses. - The recent upward move follows the departure of its Chief Financial Officer on July 12, 2026, adding to investor sentiment amidst significant volatility since its June 2026 SPAC debut. - Concerns regarding potential dilutive financing risks continue to impact share performance.